These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 15558556

  • 1. Rational discovery of a novel interface for a coactivator in the peroxisome proliferator-activated receptor gamma: theoretical implications of impairment in type 2 diabetes mellitus.
    Shiraki T, Kodama TS, Jingami H, Kamiya N.
    Proteins; 2005 Feb 01; 58(2):418-25. PubMed ID: 15558556
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T, Shiraki T, Oyama T, Fujimoto Y, Maebara K, Kamiya N, Jingami H, Morikawa K.
    J Mol Biol; 2009 Jan 09; 385(1):188-99. PubMed ID: 18977231
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.
    Li Y, Suino K, Daugherty J, Xu HE.
    Mol Cell; 2005 Aug 05; 19(3):367-80. PubMed ID: 16061183
    [Abstract] [Full Text] [Related]

  • 7. Atomic structure of mutant PPARgamma LBD complexed with 15d-PGJ2: novel modulation mechanism of PPARgamma/RXRalpha function by covalently bound ligands.
    Waku T, Shiraki T, Oyama T, Morikawa K.
    FEBS Lett; 2009 Jan 22; 583(2):320-4. PubMed ID: 19101554
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.
    Burgermeister E, Schnoebelen A, Flament A, Benz J, Stihle M, Gsell B, Rufer A, Ruf A, Kuhn B, Märki HP, Mizrahi J, Sebokova E, Niesor E, Meyer M.
    Mol Endocrinol; 2006 Apr 22; 20(4):809-30. PubMed ID: 16373399
    [Abstract] [Full Text] [Related]

  • 15. Flexible ligand recognition of peroxisome proliferator-activated receptor-gamma (PPARgamma).
    Yamagishi K, Yamamoto K, Mochizuki Y, Nakano T, Yamada S, Tokiwa H.
    Bioorg Med Chem Lett; 2010 Jun 01; 20(11):3344-7. PubMed ID: 20444603
    [Abstract] [Full Text] [Related]

  • 16. Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.
    Lu IL, Huang CF, Peng YH, Lin YT, Hsieh HP, Chen CT, Lien TW, Lee HJ, Mahindroo N, Prakash E, Yueh A, Chen HY, Goparaju CM, Chen X, Liao CC, Chao YS, Hsu JT, Wu SY.
    J Med Chem; 2006 May 04; 49(9):2703-12. PubMed ID: 16640330
    [Abstract] [Full Text] [Related]

  • 17. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.
    Solomon IH, Hager JM, Safi R, McDonnell DP, Redinbo MR, Ortlund EA.
    J Mol Biol; 2005 Dec 16; 354(5):1091-102. PubMed ID: 16289203
    [Abstract] [Full Text] [Related]

  • 18. Binding and stability determinants of the PPARgamma nuclear receptor-coactivator interface as revealed by shotgun alanine scanning and in vivo selection.
    Phillips KJ, Rosenbaum DM, Liu DR.
    J Am Chem Soc; 2006 Aug 30; 128(34):11298-306. PubMed ID: 16925449
    [Abstract] [Full Text] [Related]

  • 19. Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor gamma to PGC-1alpha.
    Li Y, Kovach A, Suino-Powell K, Martynowski D, Xu HE.
    J Biol Chem; 2008 Jul 04; 283(27):19132-9. PubMed ID: 18469005
    [Abstract] [Full Text] [Related]

  • 20. Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4.
    Ayers SD, Nedrow KL, Gillilan RE, Noy N.
    Biochemistry; 2007 Jun 12; 46(23):6744-52. PubMed ID: 17516629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.